Literature DB >> 22422628

Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer.

Wen-Wei Chang1, Fang-Wei Hu, Cheng-Chia Yu, Hsiu-Huan Wang, Hsiang-Pu Feng, Chih Lan, Lo-Lin Tsai, Yu-Chao Chang.   

Abstract

BACKGROUND: Previously, we enriched a subpopulation of head and neck cancer-derived tumor initiating cells (HNC-TICs) presented high tumorigenic, chemo-radioresistant, and coupled with epithelial-mesenchymal transition (EMT) properties. The purpose of this study was to investigate the therapeutic effect and molecular mechanisms of quercetin on HNC-TICs.
METHOD: ALDH1 activity of head and neck cancer cells with quercetin treatment was assessed by the Aldefluor assay flow cytometry analysis. Self-renewal, invasiveness, and EMT capability of HNC-TICs with different doses of quercetin was presented.
RESULTS: We first observed that the treatment of quercetin significantly downregulated the ALDH1 activity of head and neck cancer cells in a dose-dependent manner (p < .05). Moreover, quercetin reduced self-renewal property and stemness signatures expression in head and neck cancer-derived sphere cells. The migration ability of head and neck cancer-derived sphere cells was lessened under quercetin treatment partially due to the decreased productions of Twist, N-cadherin, and vimentin.
CONCLUSION: Quercetin suppressing HNC-TICs characteristics may therefore be valuable therapeutics clinically in combination with standard treatment modalities.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422628     DOI: 10.1002/hed.22982

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  17 in total

Review 1.  Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Authors:  Reem Malek; Hailun Wang; Kekoa Taparra; Phuoc T Tran
Journal:  Cells Tissues Organs       Date:  2017-02-20       Impact factor: 2.481

Review 2.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

Review 3.  Twist: a molecular target in cancer therapeutics.

Authors:  Md Asaduzzaman Khan; Han-chun Chen; Dianzheng Zhang; Junjiang Fu
Journal:  Tumour Biol       Date:  2013-07-20

4.  Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt/β-Catenin signaling pathway.

Authors:  Wei Xie; Yan Zhang; Shiwei Zhang; Fengxian Wang; Kunchi Zhang; Yanjuan Huang; Zhaoli Zhou; Gang Huang; Jin Wang
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 5.  Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.

Authors:  Mousumi Tania; Md Asaduzzaman Khan; Junjiang Fu
Journal:  Tumour Biol       Date:  2014-06-02

Review 6.  Targeting Twist expression with small molecules.

Authors:  Haixiang Pei; Yunqi Li; Mingyao Liu; Yihua Chen
Journal:  Medchemcomm       Date:  2016-12-02       Impact factor: 3.597

Review 7.  Polyphenols delivery by polymeric materials: challenges in cancer treatment.

Authors:  Orazio Vittorio; Manuela Curcio; Monica Cojoc; Gerardo F Goya; Silke Hampel; Francesca Iemma; Anna Dubrovska; Giuseppe Cirillo
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 8.  Epithelial to Mesenchymal Transition in a Clinical Perspective.

Authors:  Jennifer Pasquier; Nadine Abu-Kaoud; Haya Al Thani; Arash Rafii
Journal:  J Oncol       Date:  2015-09-06       Impact factor: 4.375

9.  Enhanced chemosensitivity by targeting Nanog in head and neck squamous cell carcinomas.

Authors:  Chuan-En Huang; Cheng-Chia Yu; Fang-Wei Hu; Ming-Yung Chou; Lo-Lin Tsai
Journal:  Int J Mol Sci       Date:  2014-08-25       Impact factor: 5.923

10.  Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?

Authors:  Martin Grimm; Marcel Cetindis; Max Lehmann; Thorsten Biegner; Adelheid Munz; Peter Teriete; Wiebke Kraut; Siegmar Reinert
Journal:  J Transl Med       Date:  2014-07-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.